Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge

• Sponsor: Erzincan University (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03910777
• Collaborator: (none)
• Enrollment: 390
• Location: 1
• Anticipated Duration (Months): 5.5
• Patients Per Site Per Month: 71.1

Study Details

Study Description

Brief Summary

The VitalPac Early Warning Score (VIEWS) scoring system, developed by Prytherch et al., Is an early warning system that aims to predict the first 24-hour mortality in emergency patients.

National early warning score (NEWS) is another early warning scoring system recommended by the Royal College of Physicians in London to detect early clinical deterioration in hospitalized patients.

The aim of this study was to determine the early clinical deterioration after ICU and hence the rate of admission to intensive care and to evaluate whether these two scoring systems can be used to determine early clinical deterioration in intensive care early discharge.

Condition or Disease	Intervention/Treatment	Phase
Early Clinical Deterioration; Early Warning Score	Diagnostic Test: Early Warning Score

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 390 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge
• Anticipated Study Start Date: Aug 1, 2019
• Anticipated Primary Completion Date: Jan 1, 2020
• Anticipated Study Completion Date: Jan 15, 2020

Outcome Measures

Primary Outcome Measures

1. Number of patients recovered due to early clinical deterioration within the first 24 hours after ICU discharge [six month]

   The aim of this study is to determine the early clinical deterioration in the first 24 hours after ICU discharge and therefore the rate of admission to ICU.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• over 18 years,

• discharged from the ICU and returned within 24 hours

Exclusion Criteria:

• under 18 years old, postoperative patients, pregnant women

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Erzincan University	Erzincan		Turkey	24100

Sponsors and Collaborators

• Erzincan University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: ILKE KUPELI, assist. prof., Erzincan University
• ClinicalTrials.gov Identifier: NCT03910777
• Other Study ID Numbers: EBYU 2
• First Posted: Apr 10, 2019
• Last Update Posted: Jul 17, 2019
• Last Verified: Jul 1, 2019

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Clinical Deterioration

Study Results

No Results Posted as of Jul 17, 2019